Security key
75943R102
Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (RLAY)
CUSIP: 75943R102
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 173,567,140
- Total 13F value
- $1,468,277,175
- Share change
- +2,872,674
- Put/Call ratio
- 4.6%
- SEC-reported price per share
- $8.46
- Number of holders
- 226
- Value change
- +$55,238,266
- Number of buys
- 109
- Number of sells
- 77
- Shares outstanding
- 218,181,818
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
226
Top holders
10
RLAY full security history
Ownership snapshot
Full 13F holder table
Relay Therapeutics, Inc. SEC filings
Relay Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Casdin Capital, LLC
Disclosed value leader
SB INVESTMENT ADVISERS (U...
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G
13F
Lead comparable stake: 7.5%
13D/G row: Casdin Capital, LLC
Showing 1-6 of 15 holder rows.
Quick read
Casdin Capital, LLC leads the comparable SEC ownership view at 7.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Casdin Capital, LLC's linked filing trail.
Comparable ownership
Top 5
Casdin Capital, LLC
7.5%
BlackRock, Inc.
6.1%
SB INVESTMENT ADVISERS (UK) LTD
13%
Commodore Capital LP
7.8%
Point72 Asset Management, L.P.
6.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Casdin Capital, LLC |
13D/G
13F
Company
|
7.5%
|
$110,010,236
13,003,574 shares
|
$0 | 31 Dec 2025 |
| BlackRock, Inc. |
13F
13D/G
Company
|
6.1%
from 13D/G
|
$71,823,974
13,759,382 shares
|
— | 30 Sep 2025 |
| SB INVESTMENT ADVISERS (UK) LTD |
13F
Company
|
13%
|
$145,663,907
27,904,963 shares
|
— | 30 Sep 2025 |
| Commodore Capital LP |
13F
Company
|
7.8%
|
$88,740,000
17,000,000 shares
|
— | 30 Sep 2025 |
| Point72 Asset Management, L.P. |
13F
Company
|
6.8%
|
$77,118,589
14,773,676 shares
|
— | 30 Sep 2025 |
| VANGUARD GROUP INC |
13F
Company
|
4.3%
|
$49,045,785
9,395,744 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
226
Shares
173,567,140
Rows available
226
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
195
Q4 2025 holders
226
Holder diff
31
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|